Things I read yesterday as part of my stock research activities.
New Orders Received
🟢 Belrise Industries secured a new EV platform order from a major OEM and a defense order for armored vehicles.
🟢 Jaykay Enterprises won defense orders worth ₹110 Cr for advanced equipment and an infrastructure project valued at ₹139 Cr from government bodies.
🟢 Waaree Energies received an order for 360MW solar modules from a domestic client
🟢 Panacea Biotec won a $4.75M PAHO order under long-term agreement to supply Easyfive-TT vaccine for 2026-2027.
Core Business & Regulatory
🟢 GSFC is expanding caprolactam and melamine capacities by 30% in FY27. Entered EV battery chemical development with ₹1,800 Cr capex pipeline for fertilizers and chemicals.
🟢 EaseMyTrip launched ‘Unwrap Travel Deals Sale’ offering discounts on flights, hotels, buses, cabs, and holiday packages from Nov 11-15.
Partnerships & Acquisitons
🟢 HLE Glascoat completed acquisition of Omeras business in Germany, expanding its portfolio into Glass Fused Steel products.
🟢 Firstsource invested in AppliedAI to advance enterprise automation capabilities.
Economy & Sectors
🟢 India waiting for US response on trade deal, with officials suggesting no further negotiation round needed to conclude bilateral agreement.
🟢 Gold ETF inflows remained strong at ₹7,743 Cr in October despite high prices and global uncertainties, with AUM crossing ₹1 lakh Cr mark.
🟢 India net tax collections rose 7% to ₹12.92 lakh Crores during April 1-Nov 10, with gross collections at ₹15.35 lakh Crores up 2% YoY.
🟢 SoftBank sold entire stake in Nvidia for $5.83 billion, planning fresh AI investments amid chipmaker market shifts.
Company Results
Source: Company Filings, Finvezto Toolkit
That’s it for today.
FINVEZTO.COM | Build Wealth, Systematically
At Finvezto Stock Research (Anand Ganapathy, SEBI Registered RA), we offer the following services. Do check out more details below.
Long Term Recommendations (Core Portfolio)
Medium Term Recommendations (Satellite Portfolio)
Short Term Strategies (Overlay Portfolio)
Toolkit for Stock Research (For DIY Investors & Traders)
Disclaimer: Anand Ganapathy K is a SEBI-registered Research Analyst with SEBI registration number INH000016630. This post is purely for learning purposes to understand more about the business. It does not recommend buying or selling stocks mentioned in this newsletter. Securities market investments carry market risks. Kindly review all related documents before investing.